Cargando…
Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease
BACKGROUND: Sodium glucose cotransporter-2 inhibitors (SGLT2-I) are the most recently approved drugs for type 2 diabetes (T2D). Recent clinical trials of these compounds reported beneficial cardiovascular (CV) and renal outcomes. A major cause of vascular dysfunction and CV disease in diabetes is hy...
Autores principales: | Bellanti, Francesco, Lo Buglio, Aurelio, Dobrakowski, Michał, Kasperczyk, Aleksandra, Kasperczyk, Sławomir, Aich, Palok, Singh, Shivaram P, Serviddio, Gaetano, Vendemiale, Gianluigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331534/ https://www.ncbi.nlm.nih.gov/pubmed/36051336 http://dx.doi.org/10.3748/wjg.v28.i26.3243 |
Ejemplares similares
-
Alteration of circulating redox balance in coronavirus disease-19-induced acute respiratory distress syndrome
por: Bellanti, Francesco, et al.
Publicado: (2023) -
Sarcopenia Is Associated with Changes in Circulating Markers of Antioxidant/Oxidant Balance and Innate Immune Response
por: Bellanti, Francesco, et al.
Publicado: (2023) -
Redox-Dependent Modulation of Human Liver Progenitor Cell Line Fate
por: Bellanti, Francesco, et al.
Publicado: (2023) -
Impact of senescence on the transdifferentiation process of human hepatic progenitor-like cells
por: Bellanti, Francesco, et al.
Publicado: (2021) -
Comparison of Three Nutritional Screening Tools with the New Glim Criteria for Malnutrition and Association with Sarcopenia in Hospitalized Older Patients
por: Bellanti, Francesco, et al.
Publicado: (2020)